Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start Yahoo Finance
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company Business Wire
Eli Lilly (NYSE: LLY) Builds Multi-Product GLP-1 Platform As Revenue Surges 48% And Global Approvals Mount foreignpolicyjournal.com
Why Is Omniab Stock Rallying After Eli Lilly Deal? Benzinga
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer TradingView
Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market PR Newswire
Eli Lilly Is Building a Weight Loss Drug for Every Kind of Patient The Motley Fool
Eli Lilly takes aim at illicit market for its experimental weight-loss drug CBS News
Eli Lilly sues companies that allegedly sold unapproved versions of new GLP-1 BenefitsPRO
Willis Investment Counsel Purchases 3,240 Shares of Eli Lilly and Company $LLY MarketBeat
Eli Lilly is a great company. Is it still a great stock? Investing.com
CRA looking into pharmaceutical giant Eli Lilly Canada's taxes National Post
Heritage Investors Management Corp Grows Stake in Eli Lilly and Company $LLY MarketBeat
Qsemble Capital Management LP Trims Stock Position in Eli Lilly and Company $LLY MarketBeat
TD Asset Management Inc Decreases Stock Position in Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company $LLY Position Lowered by Chilton Capital Management LLC MarketBeat
Eli Lilly and Company $LLY is Suncoast Equity Management's 5th Largest Position MarketBeat
Ascent Group LLC Purchases 1,544 Shares of Eli Lilly and Company $LLY MarketBeat
Eli Lilly files first lawsuits over retatrutide ‘black market’ Endpoints News
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C Eli Lilly and Company
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause Eli Lilly and Company
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings CNBC
Breakingviews - Eli Lilly is pharma’s latest victim of success Reuters
TCW Group Inc. Acquires 2,913 Shares of Eli Lilly and Company $LLY MarketBeat
Eli Lilly and Company $LLY Shares Purchased by SWS Partners MarketBeat
Eli Lilly (NYSE:LLY) Lifts Guidance on Retatrutide Trial Wins Kalkine Media
Massachusetts Financial Services Co. MA Raises Position in Eli Lilly and Company $LLY MarketBeat
Jennison Associates LLC Increases Position in Eli Lilly and Company $LLY MarketBeat
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug STAT
Eli Lilly and Company $LLY Shares Purchased by Hodges Capital Management Inc. MarketBeat
Mill Capital Management LLC Boosts Stock Holdings in Eli Lilly and Company $LLY MarketBeat
Lilly announces three acquisitions to build infectious disease portfolio Eli Lilly and Company
Elyxium Wealth LLC Has $7.30 Million Position in Eli Lilly and Company $LLY MarketBeat
Hardy Reed LLC Grows Holdings in Eli Lilly and Company $LLY MarketBeat
Novo Nordisk says it’s suing Eli Lilly, accusing it of false advertising NBC News
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions Eli Lilly and Company
Fire Capital Management LLC Has $2.54 Million Stock Holdings in Eli Lilly and Company $LLY MarketBeat
Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions Eli Lilly and Company
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility Eli Lilly and Company